Franklin Biotechnology Discv A Acc SGD

Performance History30/04/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv A Acc SGD
Fund102.648.940.5-27.310.1
+/-Cat7.64.8-3.11.6-1.0
+/-Idx-4.44.4-3.7-4.92.6
 
Key Stats
NAV
26/05/2017
 SGD 29.03
Day Change -0.96%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0320765992
Fund Size (Mil)
30/04/2017
 USD 2516.29
Share Class Size (Mil)
30/04/2017
 SGD 25.89
Max Initial Charge 5.75%
Ongoing Charge
27/01/2017
  1.83%
Investment Objective: Franklin Biotechnology Discv A Acc SGD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/05/2017
YTD0.68
3 Years Annualised15.57
5 Years Annualised27.93
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
25/10/2007
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A Acc SGD30/04/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks92.850.0092.85
Bonds0.000.000.00
Cash6.040.006.04
Other1.110.001.11
Top 5 Regions%
United States96.70
United Kingdom0.94
Middle East0.89
Canada0.69
Eurozone0.62
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.26
Biogen IncHealthcareHealthcare6.26
Alexion Pharmaceuticals IncHealthcareHealthcare5.86
Incyte CorpHealthcareHealthcare5.63
Tesaro IncHealthcareHealthcare5.47
Franklin Biotechnology Discv A Acc SGD